Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021;23:1447–56.

Article  PubMed  PubMed Central  Google Scholar 

Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, et al. Brain metastases: a society for neuro-oncology (SNO) consensus review on current management and future directions. Neuro Oncol. 2022;24:1613–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, et al. Brain metastases. Nat Rev Dis Primers. 2019;5:1–26.

Article  Google Scholar 

Kim AE, Nieblas-Bedolla E, de Sauvage MA, Brastianos PK. Leveraging translational insights toward precision medicine approaches for brain metastases. Nat Cancer. 2023;4:955–67.

Article  PubMed  PubMed Central  Google Scholar 

Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 2015;5:1164–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferraro E, Singh J, Patil S, Razavi P, Modi S, Chandarlapaty S, et al. Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab. Npj Breast Cancer. 2022;8:1–8.

Article  Google Scholar 

Reese RA, Lamba N, Catalano PJ, Cagney DN, Wen PY, Aizer AA. Incidence and predictors of neurologic death in patients with brain metastases. World Neurosurgery. 2022;162:e401–15.

Article  PubMed  Google Scholar 

Sammons S, Leone J, Sanglier T, Lambert P, Montemurro F, Poppe R, et al. Abstract PS11–01: Brain metastases in metastatic breast cancer: prevalence per line of treatment and cumulative incidence in a cohort of 18075 real-world patients. Cancer Res. 2024;84:PS11-01.

Article  Google Scholar 

Darlix A, Louvel G, Fraisse J, Jacot W, Brain E, Debled M, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort. Br J Cancer. 2019;121:991–1000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loibl S, Mano M, Untch M, Huang C-S, Mamounas E, Wolmark N, et al. Abstract GS03–12: Phase III study of adjuvant ado-trastuzumab emtansine vs trastuzumab for residual invasive HER2-positive early breast cancer after neoadjuvant chemotherapy and HER2-targeted therapy: KATHERINE final IDFS and updated OS analysis. Cancer Research. 2024;84:GS03-12.

Article  Google Scholar 

Pusztai L, Denkert C, O’Shaughnessy J, Cortes J, Dent R, McArthur H, et al. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 ☆. Annals of Oncology [Internet]. 2024 [cited 2024 Apr 30];0. Available from: https://www.annalsofoncology.org/article/S0923-7534(24)00046-2/fulltext

Lin NU, Murthy RK, Abramson V, Anders C, Bachelot T, Bedard PL, et al. Tucatinib vs placebo, both in combination with trastuzumab and capecitabine, for previously treated erbb2 (HER2)-positive metastatic breast cancer in patients with brain metastases: updated exploratory analysis of the HER2CLIMB randomized clinical trial. JAMA Oncol. 2023;9:197–205.

Article  PubMed  Google Scholar 

Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, et al. Brain metastases in newly diagnosed breast cancer: a population-based study. JAMA Oncol. 2017;3:1069–77.

Article  PubMed  PubMed Central  Google Scholar 

Garber HR, Raghavendra AS, Lehner M, Qiao W, Gutierrez-Barrera AM, Tripathy D, et al. Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer. NPJ Breast Cancer. 2022;8:46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song Y, Barry WT, Seah DS, Tung NM, Garber JE, Lin NU. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Cancer. 2020;126:271–80.

Article  CAS  PubMed  Google Scholar 

Bartsch R, Jerzak KJ, Larrouquere L, Müller V, Rhun EL. Pharmacotherapy for leptomeningeal disease in breast cancer. Cancer Treatment Reviews [Internet]. 2024 [cited 2024 Apr 17];122. Available from: https://www.cancertreatmentreviews.com/article/S0305-7372(23)00146-9/fulltext

Grinda T, Joyon N, Lusque A, Lefèvre S, Arnould L, Penault-Llorca F, et al. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort. Npj Breast Cancer. 2021;7:1–9.

Article  Google Scholar 

Duchnowska R, Dziadziuszko R, Trojanowski T, Mandat T, Och W, Czartoryska-Arłukowicz B, et al. Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Res. 2012;14:R119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereslete A, Hughes M, Patterson A, Files J, Nguyen K, Buckley L, et al. Abstract PS11–06: Analysis of HER2 expression changes from breast primary to brain metastases including HER2 Low and impact on overall survival. Cancer Research. 2024;84:PS11-06.

Article  Google Scholar 

Hyun J-W, Jeong IH, Joung A, Cho HJ, Kim S-H, Kim HJ. Leptomeningeal metastasis: Clinical experience of 519 cases. Eur J Cancer. 2016;56:107–14.

Article  PubMed  Google Scholar 

Sinclair H, Le Calvez K, Chen J, Pakzad-Shahabi L, Dixon L, Mohammed W, et al. Estimating population-based incidence of brain metastases – a comprehensive incident cohort study. Neuro-Oncology. 2021;23:iv21.

Article  Google Scholar 

Clarke JL, Perez HR, Jacks LM, Panageas KS, DeAngelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tewarie IA, Jessurun CAC, Hulsbergen AFC, Smith TR, Mekary RA, Broekman MLD. Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis. Neuro-Oncol Adv. 2021;3:vdad62.

Google Scholar 

Griguolo G, Pouderoux S, Dieci MV, Jacot W, Bourgier C, Miglietta F, et al. Clinicopathological and treatment-associated prognostic factors in patients with breast cancer leptomeningeal metastases in relation to tumor biology. Oncologist. 2018;23:1289–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morikawa A, Jordan L, Rozner R, Patil S, Boire A, Pentsova E, et al. Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis. Clin Breast Cancer. 2017;17:23–8.

Article  PubMed  Google Scholar 

Niwińska A, Pogoda K, Michalski W, Kunkiel M, Jagiełło-Gruszfeld A. Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM). J Neurooncol. 2018;138:191–8.

Article  PubMed  Google Scholar 

Le Rhun E, Taillibert S, Zairi F, Kotecki N, Devos P, Mailliez A, et al. A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer. J Neurooncol. 2013;113:83–92.

Article  PubMed  Google Scholar 

Riecke K, Müller V, Neunhöffer T, Park-Simon T-W, Weide R, Polasik A, et al. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry. ESMO Open [Internet]. 2023 [cited 2024 Oct 30];8.

Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, et al. Beyond an updated graded prognostic assessment (Breast GPA) a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. Int J Rad Oncol Biol Phys. 2020;107:334–43.

Article  Google Scholar 

Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: An Analysis of 1,960 Patients in the RTOG Database. Int J Rad Oncol Biol Phys. 2008;70:510–4.

Article  Google Scholar 

Li AY, Gaebe K, Zulfiqar A, Lee G, Jerzak KJ, Sahgal A, et al. Association of brain metastases with survival in patients with limited or stable extracranial disease: a systematic review and meta-analysis. JAMA Netw Open. 2023;6:e230475.

Article  PubMed  PubMed Central  Google Scholar 

McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR, et al. Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery. Radiother Oncol. 2020;142:168–74.

Article  PubMed  Google Scholar 

Soike M, Hughes RT, Everett A, Marcrom S, Farris M, Bredel M, et al. Multi-institutional analysis of brain metastasis velocity within breast cancer receptor subtypes. Int J Radiat Oncol Biol Phys. 2020;108: e712.

Article  Google Scholar 

Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. JCO. 2022;40:492–516.

Article  CAS  Google Scholar 

Le Rhun E, Rudà R, Devos P, Hoang-Xuan K, Brandsma D, Pérez Segura P, et al. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. J Neurooncol. 2017;133:419–27.

Article  PubMed